Early symptom non-improvement and aggravation are associated with the treatment response to SSRIs in MDD: a real-world study
Hsinsung Yuan,1,2 Xiao Zhu,1 Qiang Luo,3,4 Alice Halim,5 Michael Halim,5 Hao Yao,5 Yiyun Cai,1,6 Shenxun Shi1,6 1Psychiatry Department of Huashan Hospital, Fudan University, Shanghai, People’s Republic of China; 2Psychiatry Department of Nanjing Brain Hospital, Nanjing, People&am...
Guardado en:
Autores principales: | Yuan H, Zhu X, Luo Q, Halim A, Halim M, Yao H, Cai Y, Shi S |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a3fffb5ebc9d42b394a69c5dbf313663 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The role of new antidepressants in clinical practice in Canada: a brief review of vortioxetine, levomilnacipran ER, and vilazodone
por: McIntyre RS
Publicado: (2017) -
Does early improvement in depressive symptoms predict subsequent remission in patients with depression who are treated with duloxetine?
por: Sueki A, et al.
Publicado: (2016) -
A meta-analysis of effects of selective serotonin reuptake inhibitors on blood pressure in depression treatment: outcomes from placebo and serotonin and noradrenaline reuptake inhibitor controlled trials
por: Zhong Z, et al.
Publicado: (2017) -
Selective serotonin reuptake inhibitors may lead to improved cataract surgery outcomes in patients with amblyopia
por: Xin KZ, et al.
Publicado: (2019) -
Noradrenaline plays a critical role in the switch to a manic episode and treatment of a depressive episode
por: Kurita M
Publicado: (2016)